IOVA EPS Estimates
Iovance Biotherapeutics, Inc.
$12.97
+$0.06(+0.43%)
59
Overall
60
Value
75
Tech
42
Quality
Market Cap
$5.85B
Volume
4.99M
52W Range
$1.76 - $15.30
Target Price
$13.09
IOVA EPS estimates: the consensus estimate for Iovance Biotherapeutics, Inc.'s current fiscal year is -$0.45 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IOVA EPS Estimates
- EPS estimate, current quarter
- $-0.09
- EPS estimate, next quarter
- $-0.11
- EPS estimate, current year
- $-0.45
- EPS estimate, next year
- $-0.22
- EPS growth, 3-year
- +24.07%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.09 |
| 2024 | $-1.28 |
| 2023 | $-1.89 |
| 2022 | $-2.49 |
| 2021 | $-2.23 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IOVA | $12.97 | +0.4% | 4.99M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW